AC Immune SA (ACIU) Soars On FDA Fast Track News πŸ“£

daz888888888
2023-06-28

$AC Immune SA(ACIU)$ 

The AC Immune SA stock price gained 71.72% on the last trading day (Tuesday, 27th Jun 2023), rising from $1.98 to $3.40. During the last trading day the stock fluctuated 75.68% from a day low at $2.18 to a day high of $3.83. The price has fallen in 6 of the last 10 days but is still up by 59.62% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 51 million more shares were traded than the day before. In total, 51 million shares were bought and sold for approximately $172.96 million.

ACIU Signals & Forecast

The AC Immune SA stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.19 and $2.16. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 23, 2023, and so far it has risen 78.95%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for AC Immune SA stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.65 between high and low, or 75.68%. For the last week, the stock has had daily average volatility of 18.64%.

The AC Immune SA stock is extremely overbought on RSI14 (76). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $3.28 (-3.48%) (This stock has high daily movements and this gives high risk. The RSI14 is 76 and this increases the risk substantially. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (ACIU) For The Upcoming Trading Day Of Wednesday 28th

For the upcoming trading day on Wednesday, 28th we expect AC Immune SA to open at $3.14, and during the day (based on 14 day Average True Range), to move between $3.16 and $3.64, which gives a possible trading interval of +/-$0.239 (+/-7.03%) up or down from last closing price. If AC Immune SA takes out the full calculated possible swing range there will be an estimated 14.07% move between the lowest and the highest trading price during the day.

Is AC Immune SA stock A Buy?

AC Immune SA holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Light up Your Investing
πŸ”₯ Join our exclusive "Light up Your Investing" campaign with Tiger! πŸ’ΌπŸ’° Participate in our game and win fantastic USD 999 prizes! πŸŽ‰πŸ€‘
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Bons
    2023-07-04
    Bons
    ok
  • YJ13
    2023-06-30
    YJ13
    good
Leave a comment
2